ARGX logo

argenx SE (ARGX) EBITDA

annual EBITDA:

-$46.35M+$293.86M(+86.37%)
December 31, 2024

Summary

  • As of today (September 8, 2025), ARGX annual EBITDA is -$46.35 million, with the most recent change of +$293.86 million (+86.37%) on December 31, 2024.
  • During the last 3 years, ARGX annual EBITDA has risen by +$325.46 million (+87.53%).
  • ARGX annual EBITDA is now -520.22% below its all-time high of -$7.47 million, reached on December 31, 2011.

Performance

1-year change

+86.37%

3-year change

+87.53%

5-year change

+77.56%

15-year change

-50.39%

ARGX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

32.23%
ARGX annual EBITDA is higher than 32.23% of companies in Healthcare sector

Range

All-time high

-$7.47M

3-year low

-$641.62M

Earnings dates

Last annual earnings report date

Dec 31, 2024
ARGX previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
ARGX next annual earnings announcement has not yet been scheduled

OtherARGXincome statement metrics

Annual revenue

$2.19B
ARGX annual revenue is $2.19 billion

annual net income

$831.57M
ARGX annual net profit is $831.57 million

annual EBIT

-$63.85M
ARGX annual earnings before interest & taxes is -$63.85 million

Annual EPS

$13.90
ARGX annual earnings per share is $13.90

quarterly EBITDA:

$239.46M+$63.40M(+36.01%)
June 30, 2025

Summary

  • As of today (September 8, 2025), ARGX quarterly EBITDA is $239.46 million, with the most recent change of +$63.40 million (+36.01%) on June 30, 2025.
  • Over the past year, ARGX quarterly EBITDA has increased by +$245.99 million (+3768.20%).
  • ARGX quarterly EBITDA is now at all-time high.

Performance

3-month change

+36.01%

1-year change

+3768.2%

3-year change

+241.17%

5-year change

+207.91%

ARGX quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

93.3%
ARGX quarterly EBITDA is higher than 93.3% of companies in Healthcare sector

Range

All-time high

$239.46M
ARGX quarterly EBITDA is currently at an all-time high

3-year low

-$169.63M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
ARGX previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
ARGX next earnings announcement is scheduled for Oct 30, 2025

OtherARGXincome statement metrics

Quarterly revenue

$947.96M
ARGX quarterly revenue is $947.96 million

quarterly net income

$245.36M
ARGX quarterly net profit is $245.36 million

quarterly EBIT

$288.02M
ARGX quarterly earnings before interest & taxes is $288.02 million

Quarterly EPS

-
ARGX quarterly earnings per share value is unknown

TTM EBITDA:

$589.82M+$245.99M(+71.54%)
June 30, 2025

Summary

  • As of today (September 8, 2025), ARGX TTM EBITDA is $589.82 million, with the most recent change of +$245.99 million (+71.54%) on June 30, 2025.
  • Over the past year, ARGX TTM EBITDA has increased by +$596.35 million (+9135.29%).
  • ARGX TTM EBITDA is now at all-time high.

Performance

3-month change

+71.54%

1-year change

+9135.29%

3-year change

+250.64%

5-year change

+365.8%

ARGX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

91.63%
ARGX TTM EBITDA is higher than 91.63% of companies in Healthcare sector

Range

All-time high

$589.82M
ARGX TTM EBITDA is currently at an all-time high

3-year low

-$391.54M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
ARGX previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
ARGX next earnings announcement is scheduled for Oct 30, 2025

OtherARGXincome statement metrics

TTM revenue

$3.05B
ARGX TTM revenue is $3.05 billion

TTM net income

$1.28B
ARGX TTM net profit is $1.28 billion

TTM EBIT

$667.43M
ARGX TTM earnings before interest & taxes is $667.43 million

TTM EPS

-
ARGX TTM earnings per share value is unknown

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$46.35M
ARGX annual EBITDA is -$46.35 million

annual net income

$831.57M
ARGX annual net profit is $831.57 million

annual interest expense

$0.00
ARGX annual interest expense is $0.00

annual income tax

-$792.56M
ARGX annual income tax is -$792.56 million

annual D&A

$17.50M
ARGX annual depreciation & amortization is $17.50 million

ARGX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+86.4%+3768.2%+9135.3%
3 y3 years+87.5%+241.2%+250.6%
5 y5 years+77.6%+207.9%+365.8%

ARGX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+92.8%at high+241.2%at high+250.6%
5 y5-yearat high+92.8%at high+207.9%at high+250.6%
alltimeall time-520.2%+92.8%at high+207.9%at high+250.6%

ARGX EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$239.46M(+36.0%)
$589.82M(+71.5%)
Mar 2025
-
$176.06M(+47.3%)
$343.84M(+104.9%)
Dec 2024
-$46.35M(-86.4%)
$119.53M(+118.2%)
$167.78M(+247.8%)
Sep 2024
-
$54.77M(-939.0%)
$48.24M(-839.0%)
Jun 2024
-
-$6.53M(-96.2%)
-$6.53M(-98.3%)
Dec 2023
-$340.21M(-47.0%)
-
-
Dec 2022
-$641.62M(+72.6%)
-
-
Jun 2022
-
-$169.63M(-23.6%)
-$391.54M(+76.4%)
Mar 2022
-
-$221.91M
-$221.91M
Dec 2021
-$371.82M(-24.4%)
-
-
Dec 2020
-$491.51M(+137.9%)
-
-
Dec 2019
-$206.60M(+105.2%)
-
-
DateAnnualQuarterlyTTM
Dec 2018
-$100.69M(+226.7%)
-
-
Dec 2017
-$30.82M(+28.3%)
-
-
Dec 2016
-$24.03M(+17.1%)
-
-
Dec 2015
-$20.53M(+42.9%)
-
-
Dec 2014
-$14.37M(+24.6%)
-
-
Jun 2014
-
-$4.54M(+39.7%)
-$9.86M(+6.2%)
Mar 2014
-
-$3.25M(+65.3%)
-$9.28M(+10.6%)
Dec 2013
-$11.53M(-20.1%)
-$1.97M(+1860.0%)
-$8.39M(+30.6%)
Sep 2013
-
-$100.30K(-97.5%)
-$6.43M(+1.6%)
Jun 2013
-
-$3.97M(+68.0%)
-$6.33M(+168.0%)
Mar 2013
-
-$2.36M
-$2.36M
Dec 2012
-$14.43M(+93.1%)
-
-
Dec 2011
-$7.47M
-
-

FAQ

  • What is argenx SE annual EBITDA?
  • What is the all time high annual EBITDA for argenx SE?
  • What is argenx SE annual EBITDA year-on-year change?
  • What is argenx SE quarterly EBITDA?
  • What is the all time high quarterly EBITDA for argenx SE?
  • What is argenx SE quarterly EBITDA year-on-year change?
  • What is argenx SE TTM EBITDA?
  • What is the all time high TTM EBITDA for argenx SE?
  • What is argenx SE TTM EBITDA year-on-year change?

What is argenx SE annual EBITDA?

The current annual EBITDA of ARGX is -$46.35M

What is the all time high annual EBITDA for argenx SE?

argenx SE all-time high annual EBITDA is -$7.47M

What is argenx SE annual EBITDA year-on-year change?

Over the past year, ARGX annual EBITDA has changed by +$293.86M (+86.37%)

What is argenx SE quarterly EBITDA?

The current quarterly EBITDA of ARGX is $239.46M

What is the all time high quarterly EBITDA for argenx SE?

argenx SE all-time high quarterly EBITDA is $239.46M

What is argenx SE quarterly EBITDA year-on-year change?

Over the past year, ARGX quarterly EBITDA has changed by +$245.99M (+3768.20%)

What is argenx SE TTM EBITDA?

The current TTM EBITDA of ARGX is $589.82M

What is the all time high TTM EBITDA for argenx SE?

argenx SE all-time high TTM EBITDA is $589.82M

What is argenx SE TTM EBITDA year-on-year change?

Over the past year, ARGX TTM EBITDA has changed by +$596.35M (+9135.29%)
On this page